Association Between Blood-Brain Barrier Disruption and Stroke-Associated Pneumonia in Acute Ischemic Stroke Patients After Endovascular Therapy: A Retrospective Cohort Study
Haojun Ma,Rui Chen,Nannan Han,Hanming Ge,Shilin Li,Yanfei Wang,Xudong Yan,Chengxue Du,Yanjun Gao,Gejuan Zhang,Mingze Chang
DOI: https://doi.org/10.2147/cia.s475887
IF: 3.829
2024-10-01
Clinical Interventions in Aging
Abstract:Haojun Ma, 1– 3, &ast Rui Chen, 1, &ast Nannan Han, 1– 3 Hanming Ge, 1 Shilin Li, 1 Yanfei Wang, 1 Xudong Yan, 1, 3 Chengxue Du, 1, 3 Yanjun Gao, 4 Gejuan Zhang, 1– 3 Mingze Chang 1– 3 1 Department of Neurology, The Affiliated Hospital of Northwest University, Xi'an No.3 hospital, Xi'an, People's Republic of China; 2 Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases, The Affiliated Hospital of Northwest University, Xi'an No.3 hospital, Xi'an, People's Republic of China; 3 Neurological Intensive Care Unit, The Affiliated Hospital of Northwest University, Xi'an No.3 hospital, Xi'an, People's Republic of China; 4 Department of Radiology, The Affiliated Hospital of Northwest University, Xi'an No.3 hospital, Xi'an, People's Republic of China &astThese authors contributed equally to this work Correspondence: Mingze Chang, Department of Neurology, The Affiliated Hospital of Northwest University, Xi'an No.3 hospital, Xi'an, 710069, People's Republic of China, Email Background: Stroke, particularly due to large vessel occlusion (LVO), is a major cause of mortality and disability globally. Endovascular therapy (ET) significantly improves outcomes for acute ischemic stroke (AIS) patients, but complications such as stroke-associated pneumonia (SAP) increase mortality and healthcare costs. This study investigates the association between blood-brain barrier (BBB) disruption and the increased risk of SAP and explores the relationship between BBB disruption and medium-term functional outcomes. Methods: The retrospective cohort study was performed on AIS patients enrolled between January 2019 to February 2023 who underwent ET. Patients were divided into two groups: BBB disruption and without BBB disruption. Multiple logistic regression model was conducted to measure the association between BBB disruption and SAP. Mediation analysis was used to estimate the potential mediation effects on the associations of BBB disruption with SAP. A restricted cubic spline (RCS) regression model was used to further outline the connection between the highest CT value of hyperattenuated lesions areas and the risk of SAP. Results: The study included 254 patients who underwent endovascular therapy, with 155 patients in the BBB disruption group (exposure) and 99 patients in the without BBB disruption group (control). Multiple logistic regression analysis revealed a significantly increased risk of SAP in patients with BBB disruption (OR = 2.337, 95% CI: 1.118– 4.990, p = 0.025). Furthermore, mediation analysis suggested that this association may be partly due to malignant cerebral oedema and haemorrhagic transformation. The study found an inverse L-shaped dose-response relationship between the maximum CT values of BBB disruption areas and the incidence of SAP. SAP partially mediated the association between BBB disruption and 3-month poor functional outcome. Conclusion: BBB disruption are a potential risk factor for SAP. BBB disruption may affect short- and medium-term prognosis of patients after ET in part through SAP. Keywords: acute stroke, stroke-associated pneumonia, hyperattenuated lesions, endovascular therapy, blood-brain barrier disruption Stroke is recognized as the second primary cause of death in high-income nations. 1,2 The Global Burden of Disease (GBD) study reported a substantial increase in stroke incidence and mortality from 1990 to 2019. 3 However, the burden of stroke is markedly higher in low- and middle-income countries, where healthcare infrastructure and resources for prevention and treatment are often insufficient. 4 In China, stroke has become the leading cause of death, with a significant increase in both the incidence and mortality rates over the past decades. 5 Data from 2020 show that stroke incidence reached 505.2 per 100,000 person-years, with 2.3 million stroke-related deaths. 6 Acute ischemic stroke caused by large vessel occlusion (LVO), which accounts for approximately one-third of stroke cases, is particularly concerning due to its association with severe disability and significantly higher mortality rates, making it a critical focus for treatment and prevention strategies. 7 In recent years, endovascular therapy (ET) has evolved as a promising treatment modality for patients with acute ischemic stroke and LVO, markedly improving outcomes in this group. 8 Nevertheless, in instances of severe stroke complications, the potential advantages of endovascular therapy may be diminished or negated. Stroke-Associated Pneumonia (SAP), a nota -Abstract Truncated-
geriatrics & gerontology,gerontology